In a large systematic review and meta-analysis, the CV effects of different GLP1-RAs were evaluated in patients with type 2 diabetes mellitus, and it was found that major cardiac events, cardiovascular death, myocardial infarction, and stroke were significantly reduced [80]. This evidence concerns the gene GCG and type 2 diabetes mellitus.